Skip to content
NewsBlazeAU – Lifestyle
Author:
Femasys Inc.
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
May 11, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
May 7, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
April 26, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
April 24, 2026
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
April 16, 2026
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
March 10, 2026
←
Previous Page
1
2